RAB5C and precursor B-cell acute lymphoblastic leukemia: Thus, while future studies may find additional targets of miR-509-5p and/or miR-509-3p that contribute to miR-509-mediated growth inhibition, our current results demonstrate that RAB5C is a novel target of miR-509 and an important driver of the growth of human B-ALL cells.